
    
      Evaluation criteria

        -  Pharmacokinetic assessment with plasma concentrations of proguanil and cycloguanil

        -  Safety assessments with adverse event monitoring including subjective/objective
           symptoms, physical examination, vital signs, electrocardiogram, and laboratory tests
    
  